Sitemap Contact

News

    See MoreBiovitrum and Symphogen Report Positive Clinical Results in Novel Rh-immunization Prevention Project
    See MoreSymphogen-Biovitrum Phase II Clinical Trial Initiated
    See MoreSymphogen Enters into Strategic Collaboration with Genentech for Antibody Therapeutics
  • See MoreMore news

Events

    See MoreAmerican Society of Hematology - ASH
  • December 4 - 9, 2008 San Francisco, USA
    See MoreAntibody Engineering - IBC’s 19th Annual International Conference
  • December 7 - 11, 2008 Sheraton San Diego Hotel and Marina San Diego, CA
    See MoreKeystone Symposium, Antibodies as Drugs
  • March 27 - April 1, 2009 Whistler, British Columbia
  • More events

Shortcuts

    Partners
  • See MoreBiovitrum
  • See MoreMeiji Seika Kaisha
  • See MoreGenentech
    International Documents
  • See MoreBioWorld Today
  • See MoreThe Japan Times
    Vacant Jobs
  • See MoreToxicologist
  • SYMPHOGEN A/S
  • Elektrovej Building 375
  • 2800 Lyngby, Denmark
  • Tel. +45 4526 5050
  • Fax. +45 4526 5060
  • info@symphogen.com
  • www.symphogen.com